ROLIFERATION and differentiation of myeloid cells
are complex processes that require not only adequate stem cell number and function, but also growth-promoting peptides.' Both indirect and direct evidence suggest that cellcell interactions' occurring at the surface membrane play a regulatory role in hematopoiesis.' Several recent observations have implicated cell surface membrane-associated growth factors in the survival and growth of mammalian cells, including hematopoietic progenitors.'. ' One such growth factor, murine macrophage colony-stimulating factor (M-CSF) or colony-stimulating-factor-l (CSFl), a homodimeric glycoprotein that stimulates differentiation, proliferation, and survival of mononuclear phagocytes,' may express activity at the cell surface. Using nonviable NIH-3T3 fibroblasts expressing the membrane form of human M-CSF, Stein et a1 reported that chemically fixed cells stimulate immortalized spleen cells bearing the M-CSF receptor via direct physical contact.' Another membranebound growth factor, transforming growth factor (TGF)-a, transmits a signal to target cells during cell-cell contact even after it has been genetically altered to eliminate proteolytic cleavage
The cell surface may participate in intercellular communi-membrane-derived vesicles in medium conditioned by cells transfected with cDNA for M-CS-T and in the vesicle-free supernatants of medium conditioned by cells transfected with cDNA for MM-CSF-a. In addition, nuclear, mitochondrial, and plasma membrane subfractions of stably transfected cells were prepared and assayed for activity. Concentration-dependent stimulation of macrophage colony formation was observed with purified plasma membranes (but not nuclear or cytosolic proteins) from cells transfected with cDNAfor M-CSF-T. By contrast, membranes from untransfected cells and cells transfected with cDNA for [slM-CSF-a or control DNA expressed no activity. Together, the data indicate that human M-CSF is expressed at the cell surface and exfoliated in association with surface membrane-derived vesicles. 0 1994 b y The American Society of Hematology.
cation not only by direct physical contact, but also by forming and releasing portions of the membrane that carry signal molecules such as class I and I1 major histocompatibility antigens (MHC),' and both positive and negative erythroiddirected growth signal^.'.'^ Results from our laboratory indicate that expression of such membrane-bound growth factors requires close cell-cell association. ' Many cells, including mononuclear cells of the bone marrow, exfoliate vesicles in vitro and in vivo.2 Shedding of surface membrane components can take a variety of forms, including (1) exfoliation of small portions of membrane, as discrete, sealed extracellular vesicles, (2) release of large sheets (or blebs) of membranes, and (3) release of proteolipid aggregates.'.'' Work from our laboratory'' and that of Van Blitterswijk et all3 suggests that rather than being random, shedding is a directed process. Membrane-bound burst-promoting activity (mBPA) is an integral membrane glycoprotein that is expressed not only by intact plasma membranes, but also by vesicles exfoliated from the surface of B lymphocyte~.'~,'' mBPA expression at the cell surface requires energy consumption, intracellular metabolism, mRNA synthesis, and translation and posttranscriptional processing. '' In the present study, we provide evidence that the membrane-associated form of human M-CSF expresses activity for human bone marrow mononuclear target cells while physically associated with the membrane, and also in association with vesicles that have been shed from the surface into liquid culture medium. In this respect, surface expression and release of M-CSF are similar to that of mBPA.
pDC201 (a derivative of pMLSV), using previously published methTransient transfection of COS cells with M-CSF variants. Plasmids containing cDNAs for each form of M-CSF were transfected into COS-l cells, using the calcium-phosphate technique." COS-l cells (ATCC CRL 1650, American Type Culture Collection, Rockville, MD) were cultured in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, NY) supplemented with 10% (voU vol) fetal calf serum (FCS; GIBCO), penicillin G (100 UlmL), and streptomycin sulfate (100 pg/mL). Cells grown to confluence were split into 10 cm dishes the day before transfection, and were fed with 10 mL DMEM with 10% FCS and antibiotics at 2 to 3 hours before transfection. Purified DNA (5 pg) was suspended in 450 pL sterile water and 50 pL 2.5 m o m CaC12 was added. Five hundred microliters of 2X HEPES buffered saline (HeBS), pH 7.05, was placed in a sterile tube. With constant agitation of the HeBS, the DNA/CaC12 mixture was added dropwise with a Pasteur pipette, vortexed, and allowed to sit at room temperature for 15 to 20 minutes. The precipitate was then distributed evenly over a 10-cm dish of cells, and the dish gently agitated for 8 hours, after which the medium was removed. The cells were washed twice with phosphatebuffered saline (PBS) and fed with DMEM containing 10% FCS. Conditioned medium from transfected cells was aspirated 72 hours after transfection and tested for M-CSF activity, as described below.
Stable transfections of COS-l cells. Purified DNA (5 pg) and DNA for Neo R (0.5 pg) was used for transfections, using the calcium-phosphate technique. Eight hours after transfection, the cells were washed twice with PBS and fed with DMEM and 10% FCS. After a 24-hour incubation at 3 7 T , cells were placed in medium containing 400 pg/mL G418, and maintained for 2 to 3 weeks. When colonies appeared, they were removed with trypsin-EDTA, and replated with DMEM containing 10% FCS and (3418. Surviving colonies were weaned from G418 and later reselected in (3418, using standard methods.
Plasma membrane preparation. Plasma membranes were isolated from COS cell lines, which have incorporated cDNAs for each variant of M-CSF (as well as control DNA for Neo R alone) and which express the protein as determined by the bioassay methods of Dainiak and Cohen? Briefly, COS cells were homogenized in a Dounce homogenizer or by sonication. All buffers contained the protease inhibitors ~-l-tosylamide-2-phenyl-ethylchloromethyl ketone (TPCK; Sigma Chemical CO, St Louis, MO), tosyl-L-lysine chloromethyl ketone (TLCK) (Sigma) and phenyl-methyl sulfonyl fluoride (PMSF; Sigma) at IO-' m o m concentration. The homogenate was subjected to isopycnic centrifugation to sequentially remove nuclear, cytosolic, and mitochondrial proteins, and the crude plasma membrane fraction was purified by centrifugation over a gradient of 40%, 30%, and 20% wt/vol sucrose in 5 mmoVL Tris, pH 7.4, as previously described.' Plasma membrane purity was monitored in each gradient fraction by measuring alkaline phosphatase activity, using standard methods." Using I3'I-wheat germ agglutinin-labeled cells, we have previously observed that plasma membranes sediment at the 30% to 40% interface of a discontinuous sucrose gradient.' Typically, plasma membranes are enriched by 10-fold to 15-fold in samples obtained at this interface. Fractions enriched for plasma membranes were diluted in 5 mmom Na-phosphate, pH 7.4, washed three times in Na-phosphate, and assayed for protein content before adding to culture. In some cases, plasma membranes were incubated at 100°C for 10 minutes, before adding to marrow culture.
Extracellular vesicle preparation and electron microscopy. Transfected COS cells expressing M-CSF variants were cultured at 37°C CO2 in humidified air for 2, 4, 8, or 16 hours in DMEM in the absence of serum. Viability of more than 99% was confirmed after 16 hours by exclusion of trypan blue. Approximately 50 to 100 mL of liquid conditioned medium were decanted, and the shed &..17.18 extracellular vesicles were collected by ultracentrifugation at 40, OOOg for 16 hours. The amounts of activity in pelletable membrane-derived vesicles resuspended to their original volume in fresh DMEM were compared to that expressed in vesicle-free supernatants of conditioned medium. Pellets of spent medium, resuspended in 20 mmom Tris buffer, were diluted 1 5 with distilled water and 5 pL were applied to Formvar (Ladd Research Industries, Burlington, VT)-coated specimen grids. After negative staining with 1% phosphotungstic acid, the grids were examined and photographed in a JEOL 1, OOOX transmission electron microscope (JEOL Ltd, Tokyo, Japan).
Protein determination. Amounts of protein present in plasma membranes and extracellular plasma membrane-derived vesicles were quantified according to the method of Lowry et a1," using a bovine serum albumin standard.
Progenitor cell collection and processing. Approximately 1 to 2 mL heavily spiculated human bone marrow was obtained from healthy paid volunteer donors after informed consent was obtained, according to institutional review board policy. Light-density mononuclear cell populations were cultured in a fibrin clot-based assay (see below). Purified plasma membranes, plasma membrane-derived vesicles or vesicle-free supernatants, all derived from transfected COS cells, were added to culture in a IO-pL volume. Assays were performed by adding 1 to 100 pg proteidml plasma membranes or vesicles shed from 6 X 10' COS cellslmL serum-free medium and 10 pg protein/mL nuclear, cytosolic or plasma membrane subfractions of stable cell lines.
Freshly aspirated bone marrow was layered over an equal volume of Ficoll-Paque (Pharmacia, Piscataway, NJ) and centrifuged at 700g for 30 minutes. Mononuclear cells at the interface were removed, washed in PBS, and relayered over Ficoll-Paque to remove residual contaminating erythrocytes. Washed mononuclear cells were centrifuged at 400s for 10 minutes, and contaminating platelets were removed by aspiration. The remaining cells were diluted in Iscove's modified Dulbecco's medium (IMDM; GIBCO), washed, and resuspended at a density of 5 X 10'lmL. After incubation in plastic tissue culture flasks, 37"C, 5% CO2 in humidified air for 2 hours, nonadherent cells were removed and washed for use in colonyforming assays. A double adherence was performed to remove more than 99% M-CSF-producing marrow cells.
Fibrin clot cultures with biochemically dejined medium. Biologic activity was assessed as stimulation of macrophage colony formation by human bone marrow incubated in IMDM, transferrin (248 pglmL), ferric chloride (1.63 pg/mL), purified human albumin (100 pglmL), aprotinin (35 U/mL), leupeptin mol/L), and a source of M-CSF, as previously described." Cells were cultured in 125-pL fibrin clots formed in microtiter wells with 0.1 mg/mL highly purified fibrinogen ( U B I AG, Stockholm, Sweden), 2 mmom CaC1, and 5 UlmL highly purified thrombin. Clots were maintained at 37"C, 5% CO2 in humidified air for 14 days, after which they were removed from culture, fixed to glass slides, and stained with hematoxylin and eosin or for alpha-naphthyl butyrate esterase activity. Mean 2 SE macrophage colonies were scored in each of four clots, and M-CSF activity was quantified, as described previously.21 Representative results of three experiments per study are presented. cells. Figure 1 shows that whereas medium conditioned by cells transfected with cDNAs for M-CSF-T or [s]M-CSF-a augments the formation of macrophage colonies by 2.33-fold and 2.83-fold, respectively, medium prepared from COS-cells transfected with control DNA has no effect. There was no effect of medium conditioned by untransfected COS cells on macrophage colony formation, relative to liquid culture medium alone (data not shown). These results indicate that M-CSF is released into liquid culture medium from COS cells transfected with cDNA for either the membrane-bound form or soluble form of the growth factor.
RESULTS

Expression
To obtain quantities of M-CSF-expressing cells sufficient for subcellular studies of the growth factor, stable cell lines were developed by introducing plasmids containing cDNAs for M-CSF-T or [s]M-CSF-a into COS cells, together with the Neo R gene, and selecting the transfected clones that were antibiotic resistant. As shown in Fig 2, liquid culture media conditioned by cells belonging to the A5, A7, B 11, and B6 lines express M-CSF activity in the fibrin clot assay, while media conditioned by cells transfected with the Neo R gene alone (C6 and C9) express no activity.
Expression of M-CSF activity on the plasma membrane.
To localize M-CSF activity within cells, subcellular fraction of COS cells transfected with cDNA for either M-CSF-T (line B 11) or [s]M-CSF-a (line A7) were prepared by ratezonal centrifugation. Biologic activity was assayed in subcellular fractions enriched for nuclear, cytosolic and plasma membrane proteins. Figure 3 shows that relative to subcellular fractions obtained from COS cells transfected with the Neo R gene, fractions obtained from cells transfected with cDNA for M-CSF-T (line B1 1) expressed significant levels of M-CSF. Activity was localized to the fraction enriched for plasma membranes from the B1 1 line (Fig 3) . Plasma membranes, incubated at 100°C for 10 minutes before culture, expressed no activity. Similar results were obtained in cultures containing plasma membranes prepared from the B6 line (data not shown).
By contrast, plasma membranes obtained from cells transfected with cDNA for [s]M-CSF-a (line A7) expressed no activity. This would be expected because the cDNA for [s]M-CSF-a encodes soluble M-CSF activity, which is never associated with the plasma membrane during processing." Nevertheless, activity was detected in the spent medium (Fig  3) , indicating that the A7 cell line is capable of releasing soluble M-CSF into liquid medium.
Stably Transfected Cell Line 
org From
Localization of M-CSF activity to extracellular vesicles in conditioned medium. To assess whether COS cells release plasma membrane-derived vesicles into liquid culture medium, resuspended pellets of medium conditioned by control or transfected COS cells were negatively stained and examined by transmission electron microscopy. As shown in Fig  4, the pellets contained numerous vesicles ranging from 40 to 70 nm in diameter. A few larger vesicles and apparent plasma membrane-derived fragments or sheets were also present. The size, number, and overall appearance of pellets from untransfected and transfected cells were similar.
It is possible that all M-CSF activity present in liquid culture medium conditioned by COS cells transfected with cDNA for M-CSF-T or [s]M-CSF-a is present in the soluble form. This would be consistent with the notion that regardless of the cDNA used, M-CSF is either actively secreted or released from the cell surface by proteolytic cleavage of the external domain of the transmembrane form of the growth factor. On the other hand, it is also possible that exfoliated extracellular vesicles may carry membrane-bound activity at their surface, consistent with the concept that plasma membrane-derived vesicles shuttle the membrane-bound molecule from the surface of one cell to that of another (target) cell. To assess these possibilities, extracellular vesicles were collected from spent medium by ultracentrifugation, resuspended to their original volume in fresh, serum-free DMEM, and assayed for biologic activity.
As shown in Note that extracellular membrane vesicles and plasma membranes express activity, and that activity in extracellular vesicles is increased by twofold to threefold, relative to that in plasma membranes.
free medium prepared from A7 cells contained activity, that from B1 1 cells contained no activity. Together, the data indicate that the plasma membrane form of M-CSF is expressed at high levels, not only on the surface of cells transfected with the respective cDNA, but also on membrane-derived vesicles that are shed from these cells. On the other hand, vesicle-free medium containing soluble activity is obtained only from COS cells transfected with the mutant soluble form of M-CSF.
DISCUSSION
Membrane-associated proliferative factors are important in the regulation of eukaryotic cell g r o~t h .~.~. "
Some of these factors previously regarded as primarily or solely active as soluble molecules have been recently shown to have membrane-associated forms?2-2s When genes for these factors were cloned, they were found to encode sequences for potential transmembrane domains. These molecules include TGFa:6 epidermal growth factor (EGF):7.2x M-CSF:9-3' mBPA,2." interleukin-l,'* and mast cell growth factor/stem cell factorkit ligand (SCF).24*33
Three membrane-anchored growth factors have been shown to express proliferative activity while physically attached to membrane. mBPA present on the B-lymphocyte plasma membrane and on the surface of membrane-derived vesicles that are exfoliated from the B-cell surface, supports proliferation of human erythroid burst-forming units9.I4-l6 and colony-forming units.34 TGF-a present on the surface of recombinant cell lines overexpressing the factor and mutated to remove proteolytic cleavage sites, induces tyrosine phosphorylation of the receptor for EGF/TGF-a and supports anchorage-independent cell Finally, the membrane bound form of SCF expresses hematopoietic proliferative Stromal elements in Steel mutant ( S W d ) mice (with a congenital hematopoietic microenvironmental defect) express bioactive soluble, but not membrane-associ-
, SCF activity,'6-38 suggesting that membrane-bound SCF may also have physiologic importance.
In this report, we assess directly whether M-CSF associated with the plasma membrane expresses biologic activity. While a previous report is highly suggestive that membranebound M-CSF supports the formation of macrophage colonies in direct contact with M-CSF-expressing fibroblasts that were fixed with glutaraldehyde, formalin, or ethanol, the possibility that proteases mediate the release of the activity was not excluded.6 Here, we have isolated plasma membranes from recombinant cells, and in order to prevent proteolysis of potentially active components, added multiple protease inhibitors during plasma membrane purification. Plasma membranes were then extensively washed before adding to culture to remove components that, nevertheless, may have been proteolyzed. Results in Fig 3 demonstrate that M-CSF is expressed in an abundant quantity by plasma membranes obtained from cells transfected with a cDNA for the membrane-bound form of M-CSF (but not for the soluble mutant form of M-CSF). These results strongly argue for expression of M-CSF activity while physically attached to the plasma membrane. Together with results demonstrating that contact between M-CSF-expressing fibroblasts and target BAC 1.2F5 cells is required for expression of the activity, our data support the concept that M-CSF, which is anchored in the plasma membrane, is functionally expressed in vitro.
Physical properties and lipid composition of plasma membranes directly influence the expression andlor function of cell surface proteins. For example, expression of histocompatibility antigens is profoundly altered by rendering lymphocyte plasma membranes more rigid by hydrogenation of fatty acids" or treatment with cholesterol hemi~uccinate.~" In addition, we have recently observed that fluidization of B-lymphocyte plasma membranes by incubation with phospholipids results in an increase in membrane width of approximately 0.4 nm (ie, approximately one turn of an alpha helix of a membrane-spanning protein) detectable by small angle x-ray diffraction, and in the expression of a negative regulator of erythropoiesis that is antigenically similar to mBPA.4' Conversely, activation of T lymphocytes by incubation with concanavalin A (an agent known to induce hematopoietic growth factor expression by T cells) results in altered plasma membrane fatty acid composition and cholesterollphospholipid ratio.42 Whether M-CSF expression on the plasma membrane of COS cells (or other cell types) can be altered by modifying biophysical properties of the cell surface is under investigation.
Both normal and malignant cells spontaneously shed surface components.43s44 Although not completely understood, several biochemical and physical mechanisms have been implicated in mediating the shedding process. Because acquisition and release of lipoproteins by the plasma membrane occurs as a direct function of extracellular free cholesterol concentration according to first order kinetics,"' passive transfer of lipoproteins in vesicles takes place between the plasma membrane and the extracellular fluid. Physical properties of the plasma membrane influence both the rate of extracellular vesicle formation and regions of the plasma membrane that are shed. We have reported that increasing the cholesterollphospholipid ratio and the proportion of saturated fatty acids in the lymphocyte plasma membrane results in decreased bilayer fluidity, altered composition of extracellular vesicles, and enhanced shedding." These results are consistent with the hypothesis that vertical displacement and release of plasma membrane proteins in association with shed vesicles occurs with increased membrane rigidity.46 Because exfoliation from viable lymphocytes is reduced in the presence of inhibitors of energy-dependent metabolism" or disruptors of microfilament or microtubule f~rmation,"~"~ the release of extracellular vesicles is, in part, an active cell process that may involve modification of the topographic distribution of plasma membrane components by cytoskeletal proteins. This possibility is supported by the observations that actin is associated with shed MHC antigens in vivo," and that filamentous actin copurifies with MHC class-I1 molecules extracted from the plasma membrane.'" Finally, shedding is influenced by the physical conditions (such as temperature) under which cells are maintained. Accordingly, extracellular vesicle formation is reduced at low temperatures and is accelerated by raising the incubation temperature."."
Depending on the cellular origin of extracellular vesicles, diverse functions are mediated by the shedding process. For example, vesicles shed from monocytes andor macrophages may trigger hemostasis through the expression of tissue factor.5' Moreover, Ia/Dr antigen complexes that are shed from lymphocytes initiate antigen-specific immune responses." Cell-cell communication between lymphocyte subpopulations that are important in regulating hematop~iesis~~ and hematopoietic progenitors is mediated by exfoliated vesicles as well.",'" Not only growth factor^,'^"^ but also receptors for lymphokines" and tran~ferrin'~.~' are shed from the cell surface. Here, we report that COS cells exfoliate plasma membrane-derived vesicles (Fig 4) containing lipids and integral membrane proteins into liquid culture medium. Results presented in Fig 5 demonstrate that shed extracellular vesicles express M-CSF. Activity on shed vesicles is increased. relative to that on intact plasma membranes, suggesting that M-CSF may be selectively sequestered during the shedding process. We observed a similar increase in specific activity of mBPA on shed vesicles versus intact plasma membranes from human B cells.'* The process of exfoliation may, therefore, function in extracellular signaling from one cell type (in this case, recombinant COS cells) to another (hematopoietic progenitors). Whether a subset of vesicles shed from COS cells transfected with cDNA for M-CSF expresses the activity (analogous to mBPA expression by MHC class-I1 antigen-bearing vesicles5*) or whether all shed vesicles express activity is unknown.
At least three distinct but related M A S transcribed from the M-CSF gene have been described in human cells (4.0 kb, 2.3 kb, and 1.6 kb).29 Rettenmeier et a1 provided evidence that M-CSF is synthesized as a membrane-bound precursor that is proteolytically cleaved to release the mature molecule.5y Our results do not exclude the possibility that truly soluble M-CSF is released and expressed in vitro, analogous to our finding both soluble and membrane-associated forms of mBPA.'h,47 A second M-CSF cDNA encoding a protein 
